Concomitant AID Expression and BCL7A Loss Associates With Accelerated Phase Progression and Imatinib Resistance in Chronic Myeloid Leukemia

被引：5
|
作者：
Yu, Nae [1 ]
Shin, Saeam [2 ]
Choi, Jong Rak [1 ]
Kim, Yoonjung [3 ]
Lee, Kyung-A [1 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Lab Med, 211 Eonju Ro, Seoul 06273, South Korea
[2] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Lab Med, Seoul, South Korea
[3] Yonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea
来源：
ANNALS OF LABORATORY MEDICINE | 2017年 / 37卷 / 02期
关键词：
BLAST-CRISIS; GENOMIC INSTABILITY; CELLS; MUTATOR; CML;
D O I：
10.3343/alm.2017.37.2.177
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：177 / 179
页数：3
相关论文
共 32 条
  • [1] BCL7A inhibits the progression and drug-resistance in acute myeloid leukemia
    Li, Tushuai
    Gao, Renjie
    Xu, Kaiwen
    Pan, Pengpeng
    Chen, Congcong
    Wang, Daokuan
    Zhang, Keyi
    Qiao, Jilei
    Gu, Yue
    DRUG RESISTANCE UPDATES, 2024, 76
  • [2] Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia
    Maiti, Abhishek
    Cortes, Jorge
    Ferrajoli, Alessandra
    Estrov, Zeev
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Ravandi, Farhad
    O'Brien, Susan
    Kantarjian, Hagop
    LEUKEMIA & LYMPHOMA, 2017, 58 (09) : 2240 - 2242
  • [3] A gene expression signature of primary resistance to imatinib in chronic myeloid leukemia
    de Lavallade, Hugues
    Finetti, Pascal
    Carbuccia, Nadine
    Khorashad, Jamshid S.
    Charbonnier, Aude
    Foroni, Letizia
    Apperley, Jane F.
    Vey, Norbert
    Bertucci, Francois
    Birnbaum, Daniel
    Mozziconacci, Marie-Joelle
    LEUKEMIA RESEARCH, 2010, 34 (02) : 254 - 257
  • [4] High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia
    Zhang, Xiaoyan
    Tu, Huaijun
    Yang, Yazhi
    Wan, Qian
    Fang, Lijun
    Wu, Qiong
    Li, Jian
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (03) : 358 - 367
  • [5] WT1 expression in peripheral leukocytes of patients with chronic myeloid leukemia serves for the prediction of Imatinib resistance
    Otahalova, E.
    Ullmannova-Benson, V.
    Klamova, H.
    Haskovec, C.
    NEOPLASMA, 2009, 56 (05) : 393 - 397
  • [6] Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study
    Kuo, Ching-Yuan
    Wang, Po-Nan
    Hwang, Wen-Li
    Tzeng, Cheng-Hwai
    Bai, Li-Yaun
    Tang, Jih-Luh
    Chang, Ming-Chih
    Lin, Sheng-Fung
    Chen, Tsai-Yun
    Chen, Yeu-Chin
    Tan, Tran-Der
    Hsieh, Chih-Yi
    Lin, Chinjune
    Lai, Clinton
    Miljkovic, Darko
    Chang, Cheng-Shyong
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (03) : 65 - 78
  • [7] High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
    Warsch, Wolfgang
    Kollmann, Karoline
    Eckelhart, Eva
    Fajmann, Sabine
    Cerny-Reiterer, Sabine
    Hoelbl, Andrea
    Gleixner, Karoline V.
    Dworzak, Michael
    Mayerhofer, Matthias
    Hoermann, Gregor
    Herrmann, Harald
    Sillaber, Christian
    Egger, Gerda
    Valent, Peter
    Moriggl, Richard
    Sexl, Veronika
    BLOOD, 2011, 117 (12) : 3409 - 3420
  • [8] Decreased Expression of microRNA-451 is Associated with Imatinib Mesylate Resistance in Chronic Myeloid Leukemia Patients
    Khalifa, Khaled
    Abbas, Omaima
    Abdlfattah, Raafat
    Alhassanin, Suzan
    Shehata, Amira
    Esawy, Sally
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S293 - S293
  • [9] MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia
    Liu, Y-Y
    Jiao, W-Y
    Li, T.
    Bao, Y-Y
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (19) : 8468 - 8475
  • [10] Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance
    Wu, Yi-Ying
    Lai, Hsing-Fan
    Huang, Tzu-Chuan
    Chen, Yu-Guang
    Ye, Ren-Hua
    Chang, Ping-Ying
    Lai, Shiue-Wei
    Chen, Yeu-Chin
    Lee, Cho-Hao
    Liu, Wei-Nung
    Dai, Ming-Shen
    Chen, Jia-Hong
    Ho, Ching-Liang
    Chiu, Yi-Lin
    CELL DEATH & DISEASE, 2021, 12 (10)
1234